全新好(000007.SZ):對零七投資賬面長期掛賬的應收款、應付款進行對衝核銷
格隆匯12月30日丨全新好(000007.SZ)公佈,根據《企業會計準則》、《關於上市公司做好各項資產減值準備等有關事項的通知》、《深圳證券交易所主板上市公司規範運作指引》以及《公司資產損失確認與核銷管理制度》的相關規定要求,公司按照依法合規、規範操作的原則,對控股子公司深圳市零七投資發展有限公司(“零七投資”)賬面長期掛賬的應收款497.65萬元、應付款490.59萬元(合計數)進行對衝核銷,此次核銷的應收款已按50%計提資產減值準備,與應付款對衝核銷後,預計將造成本期收益增加約242萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.